Literature DB >> 2455619

The effect of beta-agonists and antagonists on muscle growth and body composition of young rats (Rattus sp.).

P J Reeds1, S M Hay, P M Dorward, R M Palmer.   

Abstract

1. The addition of the beta-selective adrenergic agonist clenbuterol to the diet was associated with an increase in the protein and RNA of skeletal and cardiac muscle, a reduction in fat deposition and an increase in energy expenditure. 2. Neither propranolol nor atenolol blocked the effect of clenbuterol on muscle protein but both reduced its effect on cardiac and fat mass and energy expenditure. 3. Five other beta-agonists were tested. All increased the interscapular brown fat mass and lowered body fat but only two increased skeletal muscle protein. 4. It is concluded that the anabolic and anti-lipogenic actions of certain beta-agonists are mechanistically distinct.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455619     DOI: 10.1016/0742-8413(88)90234-4

Source DB:  PubMed          Journal:  Comp Biochem Physiol C        ISSN: 0742-8413


  15 in total

Review 1.  Athletes and doping: effects of drugs on the respiratory system.

Authors:  P N Dekhuijzen; H A Machiels; L M Heunks; H F van der Heijden; R H van Balkom
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

2.  Increased association of ribosomes with myofibrils during the skeletal-muscle hypertrophy induced either by the beta-adrenoceptor agonist clenbuterol or by tenotomy.

Authors:  Z Horne; J Hesketh
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

Review 3.  Regulation of protein turnover in skeletal and cardiac muscle.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

4.  Short term salbutamol ingestion and supramaximal exercise in healthy women.

Authors:  B Le Panse; A Arlettaz; H Portier; A-M Lecoq; J De Ceaurriz; K Collomp
Journal:  Br J Sports Med       Date:  2006-05-10       Impact factor: 13.800

5.  Evidence that the hypertrophic action of clenbuterol on denervated rat muscle is not propranolol-sensitive.

Authors:  C A Maltin; S M Hay; M I Delday; P J Reeds; R M Palmer
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

6.  CL 316,243, a selective beta3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle.

Authors:  Luiz Carlos C Navegantes; Neusa M Z Resano; Amanda Martins Baviera; Renato H Migliorini; Isis C Kettelhut
Journal:  Pflugers Arch       Date:  2005-08-10       Impact factor: 3.657

7.  Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats.

Authors:  M N Sillence; M L Matthews; W G Spiers; G G Pegg; D B Lindsay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

8.  Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.

Authors:  B Fagher; H Liedholm; A Sjögren; M Monti
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

9.  CL316,243, a selective β3-adrenoceptor agonist, activates protein translation through mTOR/p70S6K signaling pathway in rat skeletal muscle cells.

Authors:  Maria Concetta Miniaci; Mariarosaria Bucci; Rita Santamaria; Carlo Irace; Anna Cantalupo; Giuseppe Cirino; Pietro Scotto
Journal:  Pflugers Arch       Date:  2013-01-19       Impact factor: 3.657

10.  Salbutamol exhibits androgenic activity in vitro.

Authors:  André O von Bueren; Risheng Ma; Margret Schlumpf; Walter Lichtensteiger
Journal:  Br J Sports Med       Date:  2007-05-17       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.